Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 139Carcinoma, Intraductal, Noninfiltrating 8Neoplasm Metastasis 6Breast Carcinoma In Situ 5Breast Neoplasms, Male 4Breast Diseases 4Arthralgia 4Triple Negative Breast Neoplasms 3Ovarian Neoplasms 3Endometrial Neoplasms 3Advanced Breast Cancer 3Neoplasms 2Breast Cancer Metastatic 2Solid Tumor 1Sexual Dysfunctions, Psychological 1Sexual Dysfunction, Physiological 1Seizures 1Sarcoma 1Recurrence 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Pain 1Osteoporosis 1Obesity 1Muscle Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Locoregional Recurrence 1Invasive Breast Cancer 1Hypogonadism 1Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer 1

Interventions

Surgical Procedures, Operative 2Paclitaxel 2Doxorubicin 2Cyclophosphamide 2Carboplatin 2pertuzumab 1liposomal doxorubicin 1cemiplimab 1atezolizumab 1Trastuzumab 1Radiotherapy 1Magnetic Resonance Spectroscopy 1Indocyanine Green 1Anastrozole 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Invasive Breast Cancer × Anastrozole × Clear all
NCT01004744 2021-01-11

Pre-Surgical Intervention for Targeted Therapies for Breast Cancer

Columbia University

Phase NA Completed
10 enrolled 4 charts
Breast

Invasive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡